A team of cardiology researchers at Yonsei University's Yongin Severance Hospital has published a study that hypothermic ...

This difficult patient pushes clinical staff to their limits — but his quiet, unnoticed decline exposes critical issues in ...

Minister of Health, Dr Frank Anthony has said that over the years, capacity has increased over the years for coronary diseases with close to 600 patients ...

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

The effectiveness of rivaroxaban, a direct oral anticoagulant, in resolving acute left ventricular thrombus in patients with ST-segment elevation myocardial infarction (STEMI) was similar to that of ...

The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.

In this parallel design, randomized trial, intensive treatment of systolic blood pressure (SBP) resulted in a lower incidence ...

Aspire Biopharma (ASBP) announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral ...

Although sedentary behavior may be an evolutionarily selected trait, it is still important to try to be physically active, ...

10 Apr – Zamarul Hisham recently revealed that he now depends on medications following his recent hospitalisation due to myocardial infarction.